Therapies for Treating Hepatitis C Virus Infection
AssigneeVertex Pharmaceuticals Incorporated
InventorMargaret James Koziel
Life of this patent
Estimating the term…
Abstract
The present invention provides a treatment for Hepatitis C virus infection patients of different IL28B gentoypes. The invention therefore provides for the prevention of the clinical sequelae of Hepatitis C viral infections. The present invention also provides a treatment for liver damage and liver inflammation. In one embodiment the invention provides a therapeutic regimen comprising administering to a patient having IL28B genotype CC, CT or TT, VX-222, or a pharmaceutically acceptable salt thereof.
Claims32
A therapeutic regimen comprising administering to a patient having IL28B genotype CC, CT or TT, VX-222, or a pharmaceutically acceptable salt thereof.
A method for treating a patient infected with Hepatitis C virus having IL28B genotype CC, CT or TT, comprising administering to the patient VX-222 in an amount effective to achieve a sustained viral response.
Dependencies are inferred from the claim text.